If you run packaging compliance or artwork approvals for a brand selling in both the US and EU markets, 2026 is not a quiet year. The FDA is phasing out eight synthetic dyes and tightening inspection standards. The EU's new Packaging and Packaging Waste Regulation comes into force in August. Both changes land on your artwork. Both require label updates. And both are happening at the same time.

Most articles on this topic are written for regulatory and legal teams — what the rules say, what the penalties are, what the deadlines are. This one is written for the people who have to execute: the packaging managers, artwork coordinators, and approval workflow leads who need to translate regulatory change into updated files, new approval sequences, and a clear plan for which SKUs get touched first.

Why These Two Changes Are Happening Simultaneously

The timing is not coordinated — it is coincidental, which makes it harder to manage.

On the US side, the FDA has been building toward a more active phase of food labeling enforcement since 2024. The updated General Food Labeling Compliance Program, effective mid-2025, made the current requirements the primary reference for inspections. That means legacy labels, transitional SKUs, and private label specifications that do not reflect current standards are now more likely to be cited during routine inspections.

On the EU side, the Packaging and Packaging Waste Regulation (PPWR, Regulation EU 2025/40) entered into force in February 2025 and becomes directly applicable across all 27 member states on 12 August 2026. Unlike the directive it replaces, it requires no national transposition — one set of rules, applied identically from Lisbon to Helsinki. For brands that previously managed 27 slightly different national interpretations of the old packaging directive, this is structurally significant.

The result for artwork teams: two major regulatory systems updating their requirements in the same twelve-month window, affecting different parts of the label, with different deadlines, across potentially overlapping SKU portfolios.

What Is Actually Changing — and What It Means for Your Artwork

FDA: Synthetic Dye Phase-Out

In April 2025, the FDA announced its intention to phase out eight petroleum-based synthetic dyes from the US food supply by the end of 2026. The affected dyes include Red No. 40, Yellow No. 5, Yellow No. 6, Blue No. 1, Blue No. 2, Green No. 3, Red No. 3, Citrus Red No. 2, and Orange B.

This is currently structured as a voluntary transition rather than an outright regulatory ban — but the practical implications for artwork teams are immediate regardless of how the policy is formally characterised.

What changes on the label:

• Any product reformulating away from synthetic dyes needs its ingredient statement updated to reflect the new colorant, including the specific source name where applicable (e.g. "beetroot red" rather than "Red 40")
• Products making "no artificial colors" claims can now do so if petroleum-based dyes are entirely removed — but this claim needs to be added to artwork and its placement approved
• Conversely, products that previously used a synthetic dye and have not yet reformulated cannot make a "no artificial colors" claim, even if natural colorants are added alongside synthetic ones
• Natural colorants often result in longer ingredient declarations — artwork needs to be checked for space, legibility, and compliance with mandatory font size requirements

For a brand with a large portfolio, this is not one label change. It is a structured rollout across potentially dozens of SKUs, each at a different stage of reformulation, each requiring its own artwork update and approval cycle.

FDA: Inspection Standards and Legacy Labels

The updated FDA compliance program means that inspections now use current requirements as the baseline — including sesame allergen declarations added by FASTER Act, updated Nutrition Facts formats, and revised serving size standards. Brands that have not yet updated all labels to reflect these changes are at increased risk of citation.

What changes on the label:

• Sesame must now be declared as a major allergen — check all labels that contain sesame or sesame-derived ingredients for compliant declaration
• Nutrition Facts panels must reflect the 2016 updated format including added sugars, updated daily values, and revised serving sizes — any legacy format labels still in circulation need to be flagged and scheduled for update

EU: Packaging and Packaging Waste Regulation (PPWR)

From 12 August 2026, Regulation EU 2025/40 replaces the previous Packaging Directive across all 27 member states. For artwork and label teams, the immediate requirements that affect what appears on pack include new recyclability labelling standards and harmonised material composition information.

What changes on the label:

• Packaging must carry harmonised recyclability information — the previous patchwork of country-specific recycling symbols (Green Dot variations, national sorting instructions) begins to be replaced by a standardised EU-wide approach
• Restrictions on PFAS in food packaging begin in August 2026, and restrictions on BPA extend to most food packaging in July 2026 — for brands using affected materials, supplier documentation needs to be updated and any packaging claims reviewed
• Greenwashing restrictions tighten: environmental claims on packaging must now be substantiated under the EU Green Claims Directive timeline — vague claims like "eco-friendly" or "sustainable" without verified backing are at risk of non-compliance

What comes next on the EU timeline:

• From February 2027: member states may require digital labels (QR codes) linking to structured environmental information
• From August 2028: harmonised material composition labels required on all packaging — brands redesigning now should plan label architecture to accommodate this

The Artwork Implication That Gets Overlooked

Both regulatory changes require label updates. But the operational challenge is not the update itself — it is managing concurrent updates across the same SKU portfolio, often with overlapping approval chains.

A food brand selling a confectionery range in the US and EU faces this concretely: the US version needs an ingredient statement update for dye reformulation and a "no artificial colors" claim added. The EU version of the same product needs recyclability markings updated for PPWR compliance. Different changes, different reviewers, different compliance owners — but potentially the same base artwork file.

Without structured version control, this creates a specific failure mode: a regulatory update approved for one market gets applied to the wrong market's file, or a file approved for PPWR compliance in the EU gets sent to the US printer before the FDA ingredient update is incorporated. Both errors are difficult to catch in email-based workflows because there is no system-level gate preventing it.

The operational requirement is a workflow that treats each market version as a distinct entity with its own approval chain, while maintaining a visible relationship between shared base artwork and market-specific variants. That is not a regulatory requirement — but it is the structural condition for executing two simultaneous regulatory updates without creating a third problem.

A Practical Approach: SKU Triage Before Artwork Triage

Before touching any artwork files, the most useful thing an artwork team can do is build a triage matrix across the affected portfolio. The questions:

1. Which SKUs contain synthetic dyes covered by the FDA phase-out? These need ingredient statement updates and potentially new claim language — prioritise by reformulation timeline
2. Which US labels have not yet been updated to the current Nutrition Facts format or include sesame allergen declarations? These are inspection risks now — prioritise before the dye changes
3. Which EU-distributed SKUs require recyclability label updates for PPWR? Deadline is 12 August 2026 — work backwards from print lead times to set the artwork approval deadline
4. Which SKUs appear in both US and EU versions from a shared base file? These need coordinated update sequences — a change to the base file should trigger a parallel approval workflow for each market variant
5. Which SKUs are due for a scheduled refresh anyway? Where packaging redesigns are already planned, incorporate the regulatory updates into the existing brief rather than running a separate compliance update

The output of this exercise is a prioritised list of artwork files that need to move through approval, with the regulatory requirement, market scope, and deadline attached to each one. That is the input a platform-based workflow needs to manage the process without losing track of which version has been approved for which market.

What This Means for Approval Workflows

Regulatory updates of this scale reveal the limits of informal approval processes faster than any other operational pressure.

Email-based approval chains break down when the same file needs to go through regulatory review for the FDA change and a separate legal review for the EU recyclability claim — and both reviewers need to see the correct market-specific version, not the base file. The failure mode is not people missing the email. It is that the workflow has no structure to enforce the right sequence.

The specific capabilities that make this manageable at scale:

• Market-specific version tracking — the EU version and US version of the same SKU exist as separate entities in the system, each with their own approval status and version history
• Compliance gates by change type — a dye reformulation triggers a regulatory gate before the ingredient statement goes to print; a recyclability label change triggers a legal review gate before the EU version is released
• Parallel approval workflows — a base artwork change that affects both US and EU versions triggers simultaneous market-specific review chains, not a sequential one
• Deadline visibility — the 12 August PPWR deadline and the FDA dye phase-out timeline are visible at the project level, not buried in a spreadsheet that someone updates manually

The Bottom Line for Packaging Artwork Teams

Two major regulatory systems are updating simultaneously. The changes are different in nature — one affects what goes inside the product and how it is declared, the other affects how the packaging itself is composed and labelled. But they land on the same artwork files, go through the same approval teams, and compete for the same bandwidth in the second half of 2026.

The brands that will manage this without recalls, reprints, or missed deadlines are the ones that start with a clear SKU-level view of what needs to change, in which market, by when — and route those changes through a workflow that enforces the right approval sequence for each type of regulatory update.

The regulatory work is unavoidable. The operational chaos is not.